These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2074068)

  • 21. [Oral contraceptives and breast tumors: which pill?].
    La Vecchia C
    Riv Inferm; 1984 Mar; 3(1):54-6. PubMed ID: 6431597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the pill.
    Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pill and cancer--IPPF response.
    IPPF Med Bull; 1983 Dec; 17(6):1-2. PubMed ID: 12279693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraceptive pills. Part II: Potential complications and health benefits.
    Meeks GR; Lassiter CL
    J Miss State Med Assoc; 1990 Dec; 31(12):397-401. PubMed ID: 2287019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pill: an evaluation of recent studies.
    Rosenfield A
    Johns Hopkins Med J; 1982 May; 150(5):177-80. PubMed ID: 7043036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
    Brzezinski A; Schenker JG
    Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraception and the big "C".
    Chandran R
    Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and cancer.
    FDA Drug Bull; 1984 Apr; 14(1):2-3. PubMed ID: 6734989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives and cancer of the reproductive organs.
    Huezo C
    IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IPPF statement on oral contraceptives and cancer of the breast.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal contraception and cancer.
    Drife J; Guillebaud J
    Br J Hosp Med; 1986 Jan; 35(1):25-9. PubMed ID: 3955285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L
    J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?
    Khoo SK
    Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiologic analysis of breast and gynecologic cancers.
    Hulka BS
    Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pill and cancer of the breast and cervix uteri].
    Pedersen A
    Ugeskr Laeger; 1984 Apr; 146(14):1063-6. PubMed ID: 6730039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.